NUTX Earnings Prediction
The chart below shows how NUTX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NUTX sees a -0.07% change in stock price 10 days leading up to the earnings, and a -19.28% change 10 days following the report. On the earnings day itself, the stock moves by +3.09%. This data can give you a slight idea of what to expect for the next quarter's release.
NUTX Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
78.79M
25.62%
3.57%
Gross Margin
27.82%
146.85%
-6.17%
Operating Margin
12.80%
1132.26%
-18.63%
Net Margin
-9.09%
26.07%
-329.55%
EPS
-1.72
-37.60%
135.62%
No Data Available
NUTX Earnings Analysis
Nutex Health Inc. Common Stock Corporation (NUTX.O) Earnings Conference Call
Positive
Revenue Increase of 26%: 1. Significant Revenue Growth: Nutex Health reported total revenue of $78.8 million for Q3 2024, marking a 26% increase from $62.7 million in Q3 2023.
Adjusted EBITDA Surge: 2. Strong Adjusted EBITDA Improvement: The company achieved an adjusted EBITDA of $13.5 million in Q3 2024, a remarkable increase of 938% compared to $1.3 million in the same quarter last year.
Patient Visit Growth: 3. Increased Patient Visits: The hospital division recorded 41,668 visits in Q3 2024, reflecting an 11.3% increase over the 37,443 visits in Q3 2023.
Gross Profit Margin Improvement: 4. Improved Gross Profit Margin: Gross profit for Q3 2024 was $21.9 million, representing 27.8% of total revenue, a significant improvement from $7.1 million or 11.3% of total revenue in Q3 2023, equating to a 210% increase.
Cash Flow Surge: 5. Strong Cash Flow from Operations: Nutex Health reported net cash from operating activities of $23.1 million for the nine months ended September 30, 2024, a substantial increase of 670% from $3 million in the same period last year.
Negative
Net Loss Worsening: 1. Increased Net Loss: Nutex Health reported a net loss of $8.8 million for Q3 2024, worsening from a net loss of $5.5 million in Q3 2023, indicating a decline in profitability despite revenue growth.
Population Health Revenue Drop: 2. Population Health Revenue Decline: The Population Health division experienced a revenue drop of $1 million, from $8.1 million in Q3 2023 to $7.1 million in Q3 2024, primarily due to the divestiture of two unprofitable subsidiaries.
Lease Liability Increase: 3. Rising Lease Liabilities: Finance lease liabilities increased from $213 million to $241 million, reflecting a significant rise in obligations due to new leases for recently opened facilities.
Noncash Expense Impact: 4. High Noncash Expenses: The net loss included $8.7 million in noncash expenses, comprising a $6.7 million loss on warrant liability and a $2 million stock-based compensation expense, which significantly impacted the financial results.
Stable G&A Expenses: 5. Stagnant G&A Expenses: General and administrative expenses as a percentage of total revenue remained virtually unchanged at 12.5% in Q3 2024 compared to 12.4% in Q3 2023, indicating a lack of improvement in cost management despite revenue growth.
NUTX FAQs
How does NUTX typically perform around its earnings report dates?
Is Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
NUTX Earning Call Sentiment
Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
NUTX.O
-2.96%Positive
The earnings call summary shows strong financial performance with significant revenue and EBITDA growth, improved cash position, and debt reduction. Despite increased net loss due to noncash expenses, operational improvements and positive Q&A insights, such as expected higher Q4 patient volumes and successful NSA arbitrations, support optimism. Although there are concerns about regulatory issues and lease liabilities, the overall sentiment is positive, with strong growth and strategic initiatives outweighing potential risks. The lack of a share repurchase program is a minor negative factor, but not enough to offset the overall positive outlook.
